Breast cancer: present and future

Áreas de cooperação: 
Pessoa de contato: 
Cristina Núñez González
Hospital Universitario Lucus Augusti
Rúa Ulises Romero Nº1
Código Postal: 
Palavras chave: 
breast cancer, luminal A, luminal B, HER2-positive, and triple negative
Descrição do projeto: 
Breast cancer (BC) is the most commonly diagnosed cancer in women worldwide. Today, even though major breast cancer subtypes have been characterized, i.e., luminal A, luminal B, HER2-positive, and triple negative, little is known about the heterogeneity of breast cancer in blood. In particular, phosphoproteins secreted or shed by cancer cells constitute a largely overlooked source of biomarker candidates that could be correlated with breast cancer subtypes and/or disease status.
Principais objetivos: 
The main objective of this proposal is discovering minimally invasive protein biomarkers in blood for the early noninvasive diagnosis, classification and monitorization of different breast cancer subtypes. These new blood-based biomarkers that are highly specific could offer the potential to decrease BC morbidity as well as identify the most appropriate treatment options.

Boletim Informativo

Seleccione abajo para suscribirse

Capitalização: Redes temáticas Interact

Contactos POCTEP

Contactos  2014-2020 | Contactos 2007-2013

  • (+34) 924 20 59 58
  • C/ Luís Álvarez Lencero 3, Planta 3ª, Of. 13, 06011 BADAJOZ (Espanha)